Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peibao Capsules (胚宝胶囊) is an approved traditional Chinese medicine (TCM) developed and manufactured by Zhejiang Kangde Pharmaceutical. The primary active ingredient is fresh sheep placenta, which is processed using low-temperature enzymatic hydrolysis technology to preserve bioactive components. In the framework of traditional Chinese medicine, the drug functions to tonify kidney yang and nourish blood and essence. It is indicated for conditions associated with kidney yang deficiency and essence-blood depletion, including chronic non-bacterial prostatitis, erectile dysfunction, female menopausal syndrome, and anemia. Additionally, it is used as an adjunctive therapy for cancer and to treat respiratory conditions such as asthma and bronchitis. The product holds national traditional Chinese medicine protection status in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Peibao Capsules.